The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1361
Potassium Iodide for Thyroid Protection in a Nuclear Accident
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Potassium Iodide for Thyroid Protection in a Nuclear Accident
Even though it is unlikely that people living in the US will be at risk of significant radiation exposure from the nuclear accident in Japan, some readers have suggested a review of the use of potassium iodide (KI) in such circumstances....more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Potassium Iodide for Thyroid Protection in a Nuclear Accident
Article code: 1361b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.